Sales rise 20.83% to Rs 641.92 crore
Net profit of Marksans Pharma rose 15.80% to Rs 96.72 crore in the quarter ended September 2024 as against Rs 83.52 crore during the previous quarter ended September 2023. Sales rose 20.83% to Rs 641.92 crore in the quarter ended September 2024 as against Rs 531.24 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales641.92531.24 21 OPM %21.1421.45 -PBDT144.11131.32 10 PBT124.60113.77 10 NP96.7283.52 16Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Cristiano Ronaldo vs Croatia")
 "Women's Asian Champions Trophy 2024")
 "NSE")
 "bear market, sensex, nifty, loss, growth, investment")
 "The green energy arm of India's largest power generator, NTPC, has said in its DRHP filing that the government's restrictions on trade ties with China will adversely impact its business, given that the neighbouring country is a leader in solar and wi")
